Is JBM (Healthcare) Limited stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, JBM (Healthcare) Limited pays dividends. Last time was Tuesday 17th of September 2024 where the investors holding the stock on Thursday 15th of August 2024 were paid HKD0.0405 per share. Over the last 4 times between 2022 and 2024, JBM (Healthcare) Limited has paid HKD0.105 with an average of HKD0.03 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for JBM (Healthcare) Limited 10 years ago, but if you had invested on Friday 5th of February 2021 when the price was HKD2.16, you would have made a loss of HKD-1.270 per share or -58.80%
No, the average daily trading liquidity for JBM (Healthcare) Limited is HKD558 015 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
JBM (Healthcare) Limited has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 1.12, the company's ability to pay off the debt is good. JBM (Healthcare) Limited has a very good net profit margin of 20.12% and should have very high tolerances against inflation.
We have calculated the inflation risk for JBM (Healthcare) Limited to be low [0 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.